Close Menu

SDIX

NEW YORK (GenomeWeb News) – OriGene Technologies and SDIX today announced a definitive agreement for OriGene to buy the Life Science assets of SDIX for $16 million.

NEW YORK (GenomeWeb News) – Eppendorf this week opened its new UK headquarters in the Arlington Business Park in Stevenage.

NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Wednesday that its second-quarter revenues fell 10 percent year over year.

NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Thursday a 15 percent falloff year over year in first-quarter revenues.
The company also announced a deal with a top-10 drug firm to generate monoclonal antibodies against a GPCR target.

NEW YORK (GenomeWeb News) – SDIX today reported that its fourth-quarter revenues dipped 13 percent year over year, as its Life Science business dropped 11 percent.

NEW YORK (GenomeWeb News) – SDIX reported after the close of the market on Monday that revenues for the third quarter dropped 8 percent year over year.

The company's Life Science business improved 13 percent year over year as it expanded its product offerings and continued to invest in its Genomic Antibody technology.

Sales for its life science business increased 19 percent to $4.5 million, while food safety revenues jumped 28 percent to $1.8 million.

Despite the overall dip in revenues, the firm's life science sales increased 3 percent.

Pages

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.